Related Experiment Videos
Hamster apigmented melanoma as a model for screening of potential antineoplastic drugs
Abstract:
The authors treated the apigmented melanoma IC-Sofia in hamster with various doses of the following cytostatics: Cyclophosphamide, 6-Mercaptopurine, Vinblastine and Actinomycin D for 7 consecutive days. Determination of the tumor growth inhibition on the 8th day (early test) on the basis of tumor weight in the animals treated and untreated with cytostatics indicates that the tumor used is more sensitive to the effect of Cyclophosphamide and 6-MP and less to Vinblastine and Actinomycin D. Nevertheless sensitivity to cytostatic action is high enough for each of the cytostatic agents, depending upon the applied dose. This gives grounds to the authors to assume that hamster apigmented melanoma IC-Sofia is an adequate model for testing and evaluation of antitumor drugs.
Insights
This study found that hamster apigmented melanoma IC-Sofia is sensitive to various cytostatics like Cyclophosphamide and 6-Mercaptopurine. This suggests its potential as a model for evaluating new antitumor drugs.
Area of Science:
- Oncology
- Pharmacology
- Preclinical Cancer Research
Background:
- Melanoma is a significant form of skin cancer.
- Developing effective antitumor drugs requires reliable preclinical models.
- The hamster apigmented melanoma IC-Sofia is a potential candidate for drug screening.
Purpose of the Study:
- To evaluate the sensitivity of hamster apigmented melanoma IC-Sofia to common cytostatics.
- To determine the suitability of this melanoma model for antitumor drug testing.
Main Methods:
- Hamster apigmented melanoma IC-Sofia was treated with Cyclophosphamide, 6-Mercaptopurine, Vinblastine, and Actinomycin D for 7 days.
- Tumor growth inhibition was assessed on day 8 by comparing tumor weights between treated and untreated groups.
Main Results:
- The melanoma model demonstrated sensitivity to all tested cytostatics, with varying degrees.
- Cyclophosphamide and 6-Mercaptopurine showed higher efficacy compared to Vinblastine and Actinomycin D.
- Dose-dependent sensitivity was observed for all agents.
Conclusions:
- Hamster apigmented melanoma IC-Sofia exhibits significant sensitivity to multiple cytostatic agents.
- This melanoma model is considered adequate for the testing and evaluation of novel antitumor drugs.
- The findings support the use of this model in preclinical cancer drug development.